Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.
Category: Biomedical research
Stanford Medicine magazine’s top reads of 2020
Stanford Medicine magazine's most-read articles of 2020 were about COVID-19, grieving and chemo brain, a misunderstood side effect of chemotherapy.
How do the new COVID-19 vaccines work?
The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.
Mapping how the brain thinks, neuron by neuron
Stanford researchers have created a molecular probe designed to map how the brain works by tagging, recording and controlling functions of individual cells.
How one Stanford physician decided to get the COVID-19 vaccine
Stanford Health Care physician Megan Mahoney, MD, describes how conversations with family helped her decide to be among the first to get the COVID-19 vaccine.
Running clinical trials in a pandemic
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.
Bat-borne Nipah virus could help explain COVID-19
Understanding similarities between the Nipah virus and COVID-19 could provide clues for avoiding future novel virus outbreaks.
Famous microbiologist experiences ‘revenge of the viruses’
Famous virus hunter Peter Piot, MD, PhD, recounts his firsthand battle with COVID-19, and the second wave of chronic symptoms that left him ill for months.
Concussion: Could your genes increase your risk?
Stanford scientists have found two genes associated with concussion. Screening football players and military might identify those at higher risk.
How Stanford became a hub for COVID-19 testing
Stanford Medicine’s early development of testing for COVID-19 infection and antibodies helped guide government responses and stem local spread of the virus.
What COVID-19 has taught us about clinical trials
Stanford Medicine researcher John Ioannidis calls for transparency and the sharing of data, a lesson learned through COVID-19.
Tiny bits of RNA give window into adult congenital heart disease in Stanford study
MicroRNA in the blood holds clues to heart problems in adults born with tetralogy of Fallot, a type of congenital heart disease, Stanford research shows.
Stanford coach’s quest to save his brother: ‘God, I hope this works’
ESPN told the story of Stanford football coach David Shaw donating stem cells to save his brother, who had a rare form of lymphoma.
Stanford Medicine researchers work to stop COVID-19
Stanford Medicine researchers are investigating SARS-CoV-2 to address the COVID-19 pandemic and ultimately help restore normalcy to society.
Clues about what makes SARS-CoV-2 tick (and how to stop it)
There's a voracious appetite for information on how SARS-CoV-2, the virus responsible for the COVID-19 pandemic, works. Here it is, in a single package.
Stanford surgeon studies how to improve scoliosis treatment
Stanford researchers have several projects underway to improve imaging techniques, bracing treatment and surgeries for kids and teens with scoliosis.